ABEO•benzinga•
Abeona Therapeutics Announces AAV204, A Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration In Non-Human Primates
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga